Send to

Choose Destination
See comment in PubMed Commons below
Shock. 1999 Jan;11(1):51-7.

Influence of L-arginine, aminoguanidine, and NG-nitro-L-arginine methyl ester (L-name) on the survival rate in a rat model of hemorrhagic shock.

Author information

Defence Medical Research Institute, Ministry of Defence, Singapore, Singapore.


Nitric oxide (NO) has been implicated in the pathophysiology of hemorrhagic shock. We investigated the influence of L-arginine (the precursor of NO synthesis), N(G)-nitro-L-arginine methyl ester (L-NAME) and aminoguanidine (AG) (inhibitors of NO synthase, with selectivity toward the constitutive and inducible isoforms, respectively) on the survival rate in a rat model of hemorrhagic shock. Anesthetized, male Sprague-Dawley rats (300-350 g) were subjected to hemorrhagic shock for 30 min followed by intravenous injection (1 mL/kg) with normal saline, L-arginine (30 mg/kg), L-NAME (10 mg/kg), L-NAME+L-arginine, AG (1, 10, 100 mg/kg) or AG (100 mg/kg)+L-arginine (n = 5 per group). Hemorrhagic shocked rats treated with saline died within 90 min. In contrast, L-NAME increased the survival time to >72 h in shocked rats. AG (1, 10, and 100 mg/kg) increased the survival time of shocked animals to 150 min, 230 min, and >72 h, respectively. Shocked rats treated with L-arginine died within 80 min, and those that received L-NAME+L-arginine and AG+L-arginine died within 120 min and 110 min, respectively. L-NAME and AG (dose dependently) reduced macroscopic and microscopic injuries, nitrate/nitrite, PGE2 and creatinine production, and inhibited GOT activity in shocked animals. L-arginine reversed the beneficial effects of AG and L-NAME, suggesting the involvement of NO in the pathophysiology of hemorrhagic shock.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center